Description

Diferelin (triptorelin) Powder 0.1 mg Injections №7

Ingredients:

Active ingredient: Triptorelin acetate. Inactive ingredients may include mannitol and acetic acid for pH adjustment.

Dosage:

The usual dosage: 0.1 mg injected subcutaneously once a day.

Indications:

Diferelin (triptorelin) injections are indicated for the treatment of advanced prostate cancer, endometriosis, and central precocious puberty.

Contraindications:

Do not use Diferelin if: allergic to triptorelin or any components, pregnant, or breastfeeding.

Directions:

Follow the healthcare provider’s instructions for the correct administration of the injections. Store at room temperature away from moisture and heat.

Scientific Evidence:

Triptorelin has been extensively studied for its efficacy in various conditions. Research published in the Journal of Clinical Oncology demonstrated the effectiveness of triptorelin in managing prostate cancer by suppressing testosterone levels.

Additional Information:

Diferelin (triptorelin) acts by continuously stimulating the pituitary gland to produce and release gonadotropins, ultimately leading to a decrease in testosterone levels in men and estrogen levels in women. This mechanism is crucial in the treatment of hormone-sensitive conditions.

Comparative studies have shown that Diferelin exhibits similar efficacy to other GnRH agonists but with potentially fewer side effects, making it a preferred choice in clinical practice.